(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

DISPOSITIVO DE TESTE MODULAR UNIVERSAL

Em AnáliseUtility ModelPCT · US2020051079

Application data

Utility Model DISPOSITIVO DE TESTE MODULAR UNIVERSAL de REGENERON PHARMACEUTICALS, INC. — IPC G01N 3/04
Utility Model DISPOSITIVO DE TESTE MODULAR UNIVERSAL de REGENERON PHARMACEUTICALS, INC. — IPC G01N 3/04. Drawing published by the INPI in the Industrial Property Gazette.

Number

122026000982

Type

Utility Model

Filing

09/16/2020

Publication

02/18/2026

PCT

US2020051079

Progress at the INPI

Technical opinion to answer
  1. Filing09/16/20
  2. Publication02/18/26
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The INPI issued a technical opinion on patentability. The applicant must respond for examination to continue.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 05/26/2026. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

REGENERON PHARMACEUTICALS, INC.

US

See this company's full portfolio

Inventors

C. H. (pessoa física)

US

R. S. (pessoa física)

US

W. M. (pessoa física)

US

Technical data

IPC Classification

Priority claims

US

62/901,122 · 09/16/2019

US

62/914,274 · 10/11/2019

Abstract

DISPOSITIVO DE TESTE MODULAR UNIVERSAL. A presente invenção refere-se a um dispositivo de teste modular que é configurado para suportar rapidamente amostras de teste de diferentes configurações para teste.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Conhecimento de parecer técnico

#7.1

05/26/2026

RPI 2890

Publicação do pedido de patente

#3.1

02/18/2026

RPI 2876

Notificação de pedido dividido

#2.4

02/10/2026

RPI 2875

Requerimento de pedido de patente

#2.10

Número de Protocolo '870260003909' em 15/01/2026 14:56 (WB)

01/27/2026

RPI 2873

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.